Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

OpenVigil—free eyeballs on AERS pharmacovigilance data

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Anonymous. Nat. Biotechnol. 27, 297 (2009).

  2. Pratt, L.A. & Danese, P.N. Nat. Biotechnol. 27, 601–602 (2009).

    Article  CAS  Google Scholar 

  3. Böhm, R., Cascorbi, I. & Herdegen, T. Med. Monatsschr. Pharm. 32, 453–458 (2009).

    PubMed  Google Scholar 

  4. Schulz-Du Bois, C. & Böhm, R. Pharmacopsychiatry 44, A104 (2011).

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank H. Tag for his great SQL magic, D. Mitterhuber for providing the servers and fine-tuning MySQL and Sara Hult for providing information about VigiBase.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruwen Böhm.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Böhm, R., Höcker, J., Cascorbi, I. et al. OpenVigil—free eyeballs on AERS pharmacovigilance data. Nat Biotechnol 30, 137–138 (2012). https://doi.org/10.1038/nbt.2113

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2113

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing